• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定针对爱泼斯坦-巴尔病毒新型BARF0蛋白的细胞毒性T淋巴细胞反应:抗原表达的关键作用。

Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.

作者信息

Kienzle N, Sculley T B, Poulsen L, Buck M, Cross S, Raab-Traub N, Khanna R

机构信息

EBV Unit, Queensland Institute of Medical Research, The Bancroft Centre, Herston, Queensland 4006, Australia.

出版信息

J Virol. 1998 Aug;72(8):6614-20. doi: 10.1128/JVI.72.8.6614-6620.1998.

DOI:10.1128/JVI.72.8.6614-6620.1998
PMID:9658107
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC109846/
Abstract

The Epstein-Barr virus (EBV)-encoded BARF0 open reading frame gene products are consistently expressed in EBV-positive Burkitt's lymphoma (BL) cell lines, nasopharyngeal carcinoma cell lines, and lymphoblastoid cell lines (LCLs). Here we show that the BARF0 sequence includes an HLA A*0201-restricted cytotoxic T-lymphocyte (CTL) epitope. By using theoretically predicted HLA A2 binding motifs and peptide-loaded antigen presentation-deficient T2 cells, polyclonal BARF0-specific CD8(+) CTLs were isolated from four different healthy EBV-seropositive donors but not from two seronegative donors. These CTL lines recognized the peptide epitope LLWAARPRL, which was found to be conserved in 33 of 34 virus strains originating from Caucasian, African, and Asian individuals. The BARF0-specific CTL lines could lyse EBV-negative BL cells stably transfected with the BARF0 gene but did not kill HLA A2-matched EBV-positive BL cells and LCLs in a standard 51Cr release assay. Reverse transcriptase PCR analysis demonstrated that these EBV-positive cell lines expressed significantly lower levels of BARF0 mRNA than transfected cells. This data indicated that the BARF0 epitope could be endogenously processed; however, antigen levels in the target cell were a limiting factor for the effective interaction between BARF0-expressing cells and CTLs. The limited expression of BARF0 antigen in EBV-infected BL cells and LCLs might contribute to the escape of immune recognition from virus-specific CTLs present in the host.

摘要

爱泼斯坦-巴尔病毒(EBV)编码的BARF0开放阅读框基因产物在EBV阳性的伯基特淋巴瘤(BL)细胞系、鼻咽癌细胞系和淋巴母细胞系(LCL)中持续表达。在此我们表明,BARF0序列包含一个HLA A*0201限制性细胞毒性T淋巴细胞(CTL)表位。通过使用理论预测的HLA A2结合基序和负载肽的抗原呈递缺陷型T2细胞,从四名不同的健康EBV血清反应阳性供体中分离出多克隆BARF0特异性CD8(+) CTL,但未从两名血清反应阴性供体中分离出。这些CTL系识别肽表位LLWAARPRL,发现该表位在源自高加索人、非洲人和亚洲人的34株病毒中的33株中保守。在标准的51Cr释放试验中,BARF0特异性CTL系可裂解稳定转染BARF0基因的EBV阴性BL细胞,但不杀伤HLA A2匹配的EBV阳性BL细胞和LCL。逆转录酶PCR分析表明,这些EBV阳性细胞系表达的BARF0 mRNA水平明显低于转染细胞。该数据表明,BARF0表位可被内源性加工;然而,靶细胞中的抗原水平是表达BARF0的细胞与CTL之间有效相互作用的限制因素。BARF0抗原在EBV感染的BL细胞和LCL中的有限表达可能有助于宿主中存在的病毒特异性CTL逃避免疫识别。

相似文献

1
Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.鉴定针对爱泼斯坦-巴尔病毒新型BARF0蛋白的细胞毒性T淋巴细胞反应:抗原表达的关键作用。
J Virol. 1998 Aug;72(8):6614-20. doi: 10.1128/JVI.72.8.6614-6620.1998.
2
Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.爱泼斯坦-巴尔病毒(EBV)致癌基因潜伏膜蛋白1(LMP1)内细胞毒性T细胞表位的鉴定:LMP1特异性细胞毒性T淋巴细胞对EBV感染细胞进行HLA A2超型限制免疫识别的证据
Eur J Immunol. 1998 Feb;28(2):451-8. doi: 10.1002/(SICI)1521-4141(199802)28:02<451::AID-IMMU451>3.0.CO;2-U.
3
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.爱泼斯坦-巴尔病毒潜伏膜蛋白1恢复伯基特淋巴瘤细胞内源性抗原加工:肽转运体和HLA-I类抗原表达的协同上调
Eur J Immunol. 1995 May;25(5):1374-84. doi: 10.1002/eji.1830250536.
4
Characterization of an human leucocyte antigen A2-restricted Epstein-Barr virus nuclear antigen-1-derived cytotoxic T-lymphocyte epitope.鉴定一个人类白细胞抗原 A2 限制的 Epstein-Barr 病毒核抗原 1 衍生的细胞毒性 T 淋巴细胞表位。
Immunology. 2010 Mar;129(3):386-95. doi: 10.1111/j.1365-2567.2009.03190.x. Epub 2009 Nov 16.
5
Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.从健康血清阳性个体中分离出对爱泼斯坦-巴尔病毒核抗原1肽表位具有特异性的细胞毒性T淋巴细胞:对病毒持续存在和肿瘤监测的意义。
Virology. 1995 Dec 20;214(2):633-7. doi: 10.1006/viro.1995.0076.
6
EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.EB病毒肽表位致敏可恢复人类细胞毒性T细胞对伯基特淋巴瘤细胞的识别。细胞间黏附分子-2起关键作用的证据。
J Immunol. 1993 Jun 1;150(11):5154-62.
7
Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.携带伯基特淋巴瘤的爱泼斯坦-巴尔病毒(EBV)的免疫逃逸:对EBV特异性细胞毒性T细胞敏感性的体外重建
Int Immunol. 1992 Nov;4(11):1283-92. doi: 10.1093/intimm/4.11.1283.
8
HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2.通过潜伏膜蛋白LMP2中一个确定的表位识别一系列爱泼斯坦-巴尔病毒分离株的HLA A2.1限制性细胞毒性T细胞。
J Virol. 1993 Dec;67(12):7428-35. doi: 10.1128/JVI.67.12.7428-7435.1993.
9
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.伯基特淋巴瘤细胞系中I类人白细胞抗原及爱泼斯坦-巴尔病毒编码的潜伏膜蛋白的下调。
Proc Natl Acad Sci U S A. 1987 Jul;84(13):4567-71. doi: 10.1073/pnas.84.13.4567.
10
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.蛋白酶体抑制剂诱导伯基特淋巴瘤细胞中呈现 Epstein-Barr 病毒核抗原 1 衍生的细胞毒性 T 淋巴细胞表位。
Immunology. 2011 May;133(1):105-14. doi: 10.1111/j.1365-2567.2011.03416.x. Epub 2011 Feb 22.

引用本文的文献

1
Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome.成功运用异源巨细胞病毒反应性T淋巴细胞治疗肝移植患者的严重难治性巨细胞病毒(CMV)感染:宿主抗病毒免疫重建与CMV病毒载量及CMV微小RNA组的相关性
Microorganisms. 2021 Mar 26;9(4):684. doi: 10.3390/microorganisms9040684.
2
Proteasomal inhibition triggers viral oncoprotein degradation via autophagy-lysosomal pathway.蛋白酶体抑制通过自噬溶酶体途径触发病毒癌蛋白降解。
PLoS Pathog. 2020 Feb 24;16(2):e1008105. doi: 10.1371/journal.ppat.1008105. eCollection 2020 Feb.
3
Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders.靶向爱泼斯坦-巴尔病毒(EBV)相关淋巴增殖性疾病中EBV生命周期的机会。
Front Oncol. 2019 Mar 15;9:127. doi: 10.3389/fonc.2019.00127. eCollection 2019.
4
NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.NF-κB信号传导调节鼻咽癌中爱泼斯坦-巴尔病毒BART微小RNA和长链非编码RNA的表达。
J Virol. 2016 Jun 24;90(14):6475-88. doi: 10.1128/JVI.00613-16. Print 2016 Jul 15.
5
EBV Noncoding RNAs.EBV非编码RNA
Curr Top Microbiol Immunol. 2015;391:181-217. doi: 10.1007/978-3-319-22834-1_6.
6
The role of miRNAs and EBV BARTs in NPC.miRNAs 和 EBV BARTs 在 NPC 中的作用。
Semin Cancer Biol. 2012 Apr;22(2):166-72. doi: 10.1016/j.semcancer.2011.12.001. Epub 2011 Dec 10.
7
Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma.EB 病毒基因的表达与浸润 T 淋巴细胞的克隆性在 EB 病毒相关性胃癌中的研究。
Immune Netw. 2011 Feb;11(1):50-8. doi: 10.4110/in.2011.11.1.50. Epub 2011 Feb 28.
8
Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.定量研究 Epstein-Barr 病毒编码的 microRNAs 为其调控提供了新的见解。
J Virol. 2011 Jan;85(2):996-1010. doi: 10.1128/JVI.01528-10. Epub 2010 Nov 10.
9
Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing.爱泼斯坦-巴尔病毒BART微小RNA是在剪接之前从一个大内含子产生的。
J Virol. 2008 Sep;82(18):9094-106. doi: 10.1128/JVI.00785-08. Epub 2008 Jul 9.
10
Dysregulation of HER2/HER3 signaling axis in Epstein-Barr virus-infected breast carcinoma cells.爱泼斯坦-巴尔病毒感染的乳腺癌细胞中HER2/HER3信号轴的失调
J Virol. 2007 Jun;81(11):5705-13. doi: 10.1128/JVI.00076-07. Epub 2007 Mar 21.

本文引用的文献

1
Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes.爱泼斯坦-巴尔病毒(EBV)致癌基因潜伏膜蛋白1(LMP1)内细胞毒性T细胞表位的鉴定:LMP1特异性细胞毒性T淋巴细胞对EBV感染细胞进行HLA A2超型限制免疫识别的证据
Eur J Immunol. 1998 Feb;28(2):451-8. doi: 10.1002/(SICI)1521-4141(199802)28:02<451::AID-IMMU451>3.0.CO;2-U.
2
Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells.鼻咽癌(NPC)中抗原处理功能的分子特征:NPC细胞有效呈递爱泼斯坦-巴尔病毒细胞毒性T细胞表位的证据
Cancer Res. 1998 Jan 15;58(2):310-4.
3
Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro.
J Immunol. 1997 Aug 15;159(4):1844-52.
4
Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.人类细胞毒性T淋巴细胞对爱泼斯坦-巴尔病毒感染的反应。
Annu Rev Immunol. 1997;15:405-31. doi: 10.1146/annurev.immunol.15.1.405.
5
Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.爱泼斯坦-巴尔病毒BamHI A区域编码的一种新型蛋白质的鉴定。
J Virol. 1997 Apr;71(4):2765-71. doi: 10.1128/JVI.71.4.2765-2771.1997.
6
DNaseI treatment is a prerequisite for the amplification of cDNA from episomal-based genes.脱氧核糖核酸酶I处理是从基于附加体的基因扩增互补DNA的前提条件。
Biotechniques. 1996 Apr;20(4):612-6. doi: 10.2144/19962004612.
7
Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences.从新几内亚分离出一种天然存在的重组爱泼斯坦-巴尔病毒,其编码1型和2型核抗原序列。
J Virol. 1996 Jul;70(7):4829-33. doi: 10.1128/JVI.70.7.4829-4833.1996.
8
Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.基于单个肽侧链独立结合对潜在HLA - A2结合肽进行排名的方案。
J Immunol. 1994 Jan 1;152(1):163-75.
9
Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs.人B淋巴细胞体外反应过程中的细胞因子mRNA表达:B细胞肿瘤坏死因子α、白细胞介素(IL)6、IL - 10和转化生长因子β1 mRNA的动力学
J Exp Med. 1993 Aug 1;178(2):521-8. doi: 10.1084/jem.178.2.521.
10
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.爱泼斯坦-巴尔病毒潜伏膜蛋白1恢复伯基特淋巴瘤细胞内源性抗原加工:肽转运体和HLA-I类抗原表达的协同上调
Eur J Immunol. 1995 May;25(5):1374-84. doi: 10.1002/eji.1830250536.